drugset / Trial / NCT04417543

Effect of Memantine on Cognitive Impairment in Patients With Epilepsy

NCT04417543

Phase 1 Completed 100 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluate the efficacy of memantine on improving the cognitive impairment in patient with epilepsy

Timeline

Start
2018-10-01
Primary completion
2019-10-01
Completion
2020-01-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Memantine Unknown 10 mg Oral

Indications